| 1. |
中华内科杂志编辑委员会. 侵袭性肺部真菌感染的诊断标准与治疗原则(草案). 中华内科杂志, 2006, 45(8): 697-700.
|
| 2. |
牟向东, 龙爽. 侵袭性肺部真菌感染的诊断. 临床内科杂志, 2016, 33(12): 801-803.
|
| 3. |
单明珠, 颜鸣菊, 朱作斌, 等. 2007-2019 年肺部真菌感染危险因素与病原菌分布的荟萃分析. 中华医院感染学杂志, 2020, 30(2): 174-179.
|
| 4. |
Ledoux MP, Guffroy B, Nivoix Y, et al. Invasive pulmonary aspergillosis. Semin Respir Crit Care Med, 2020, 41(1): 80-98.
|
| 5. |
Patterson TF, Thompson GR, Denning DW, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis, 2016, 63(4): e1-e60.
|
| 6. |
Lin E, Moua T, Limper AH. Pulmonary mucormycosis: clinical features and outcomes. Infection, 2017, 45(4): 443-448.
|
| 7. |
Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and Diagnosis of Mucormycosis: An Update. J Fungi (Basel), 2020, 6(4): 265.
|
| 8. |
Mahalaxmi I, Jayaramayya K, Venkatesan D, et al. Mucormycosis: An opportunistic pathogen during COVID-19. Environ Res, 2021, 201: 111643.
|
| 9. |
牟向东, 王广发, 刁小莉, 等. 肺毛霉病三例临床分析. 中华结核和呼吸杂志, 2007, 30(11): 835-838.
|
| 10. |
Choueiri TK, Motzer RJ. Systemic therapy for metastatic renal-cell carcinoma. N Engl J Med, 2017, 376(4): 354-366.
|
| 11. |
Multani A, Reveron-Thornton R, Garvert DW, et al. Cut it out! Thoracic surgeon's approach to pulmonary mucormycosis and the role of surgical resection in survival. Mycoses, 2019, 62(10): 893-907.
|
| 12. |
Choi H, Lee H, Jeon K, et al. Factors affecting surgical resection and treatment outcomes in patients with pulmonary mucormycosis. J Thorac Dis, 2019, 11(3): 892-900.
|
| 13. |
张会娟, 牟向东, 尹洪芳, 等. 经导航支气管镜局部灌注两性霉素 B 治愈肺毛霉病一例. 中华结核和呼吸杂志, 2021, 44(8): 733-735.
|
| 14. |
牟向东, 蔡存良, 赵景全, 等. 虚拟支气管镜导航下经支气管镜局部灌注两性霉素 B 治疗肺曲霉病一例. 中华医学杂志, 2020, 100(30): 2391-2392.
|
| 15. |
卢鑫, 孙文逵, 高伟, 等. 雾化吸入两性霉素 B 对侵袭性肺曲霉病预防效果的 Meta 分析. 中国呼吸与危重监护杂志, 2012, 11(1): 28-36.
|
| 16. |
Duckwall MJ, Gales MA, Gales BJ. Inhaled amphotericin B as aspergillosis prophylaxis in hematologic disease: an update. Microbiol Insights, 2019, 12: 1178636119869937.
|
